|
Evaluation and Treatment of Patients with Corneal and External Diseases Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Evaluation and Treatment of Patients with Corneal and External Diseases conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Evaluation and Treatment of Patients with Corneal and External Diseases Clinical research trials and Evaluation and Treatment of Patients with Corneal and External Diseases medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Evaluation and Treatment of Patients with Corneal and External Diseases. Evaluation and Treatment of Patients with Corneal and External Diseases Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Evaluation and Treatment of Patients with Corneal and External Diseases clinical trial. Participants frequently get the best healthcare available for their Evaluation and Treatment of Patients with Corneal and External Diseases condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation and Treatment of Patients with Corneal and External Diseases  Evaluation and Treatment of Patients with Corneal and External Diseases
Evaluation and Treatment of Patients with Corneal and External Diseases
For Condition: Keratitis,Conjunctivitis,Dacryocystitis,Dacryoadenitis,Blepharitis,Corneal Disease
Status: Recruiting
Sponsor(s): National Eye Institute (NEI) ,
Synopsis: This study offers evaluation and treatment for patients with certain corneal and external diseases of the eye (diseases of the surface of the eye and its surrounding structures). The protocol is not designed to test new treatments; rather, patients will receive current standard of care treatments. The purpose of the study is twofold: 1) to allow National Eye Institute physicians to increase their knowledge of various corneal and external conditions and identify possible new avenues of research in this area; and 2) to establish a pool of patients who may be eligible for new studies as they are developed. (Participants in this protocol will not be required to join a new study; the decision will be voluntary.) Children and adults with corneal or external eye diseases may be eligible for this study. Candidates will be screened with a medical history, brief physical examination, thorough eye examination and blood test. The eye examination includes measurements of eye pressure and visual acuity (ability to see the vision chart) and dilation of the pupils to examine the lens and retina (back part of the eye). Patients will also undergo the following procedures: 1. Eye photography - Special photographs of the inside of the eye to help evaluate the status of the cornea and conjunctiva (the most superficial layer of the eye) evaluate changes that may occur in the future. From two to 20 pictures may be taken, depending on the eye condition. The camera flashes a bright light into the eye for each picture. 2. Conjunctival or lacrimal gland biopsy - A small piece of the conjunctiva or the lacrimal (tear) gland, is removed for examination under the microscope. Anesthetic drops and possibly an injection of anesthetic are given to numb the eye. An antibiotic ointment and patch may be placed over the eye for several hours after the procedure. Participants will be followed at least 3 years. Follow-up visits are scheduled according to the standard of care for the individual patient's eye problem. Vision will be checked at each visit, and some of the tests described above may be repeated to follow the progress of disease and evaluate the response to any treatment that is given.
Details: This "Evaluation and Treatment Protocol" will allow the specialists in cornea and external disease at the NEI to identify, follow and provide "standard of care" treatment to patients with various corneal and external disorders. A primary purpose of the protocol is to accumulate a cohort of patients with corneal diseases for possible participation in new NEI clinical trials and epidemiological protocols. Also, by providing long-term follow-up and treatment for a variety of corneal and external diseases, the corneal specialists at NEI will be better able to identify research hypotheses about these diseases in addition to maintaining their clinical skills. The availability of cohorts of patients with a spectrum of corneal and external diseases will be valuable for training of fellows in corneal and external disease and ocular inflammatory disease, an important mission of the NEI. The ability to provide long-term follow-up and care will also facilitate referral efforts for new NEI protocols. The cornea specialists at the National Eye Institute will be free to choose those conditions that interest them. However, the total number of patients that can be enrolled in the protocol will be restricted. This protocol is not designed to test any new treatments. Any evaluations or treatment under this protocol will be based on the current standard of care for each corneal or external disease. Participants in this patient evaluation and treatment protocol will be evaluated for potential eligibility in any new NEI clinical trials or epidemiologic protocols as they are developed. If eligible, patients may be asked to participate in the new protocol. However, they will not be required to enter any protocol and their decision to participate will entirely voluntary. No more than 200 patients will be accepted in this "Evaluation and Treatment Protocol."
Eligibility:
Study Type: Interventional, Training
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Must have the ability to understand and sign an informed consent or assent form. The consent must be signed prior to enrollment. Children of all ages are eligible to be included in this protocol. Patients will be excluded from this study if they are unable or unwilling to give informed consent or they are unwilling to be followed and treated at the NEI clinical center for at least the next three years.
Total Enrollment: 250
Location and Contact Information:
National Eye Institute (NEI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 010046; 01-EI-0046
Study Start Date: January 2, 2001
Record last reviewed: November 3, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00008541
Other Dacryocystitis Studies:
1. Evaluation and Treatment of Patients with Corneal and External Diseases
2. Screening for NEI Clinical Studies
3. Structure of the Herpes Simplex Virus Receptor
Related Studies:
Other Dacryocystitis Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluation and Treatment of Patients with Corneal and External Diseases
|
|
|
|
|
|
|
|
